Cargando…
AVEXIS technology identifies novel platelet-leukocyte binding partners including CD148-CD300a
Autores principales: | Barroso, Ruben, Bicknell, Roy, Rainger, George Ed, Watson, Steve P., Sun, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153046/ https://www.ncbi.nlm.nih.gov/pubmed/34555847 http://dx.doi.org/10.1182/bloodadvances.2021004546 |
Ejemplares similares
-
Differential expression of CD148 on leukocyte subsets in inflammatory arthritis
por: Dave, Richa K, et al.
Publicado: (2013) -
The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis
por: Senis, Yotis A., et al.
Publicado: (2009) -
The role of platelets in the recruitment of leukocytes during vascular disease
por: Ed Rainger, G., et al.
Publicado: (2015) -
Synapse too exclusive for CD148
por: LeBrasseur, Nicole
Publicado: (2003) -
Avidity-based Extracellular Interaction Screening (AVEXIS) for the Scalable Detection of Low-affinity Extracellular Receptor-Ligand Interactions
por: Kerr, Jason S., et al.
Publicado: (2012)